Stealth Beadlets, page-2

Guessing that: At the shareholder briefing the question was asked about other things in the pipeline, and the value of other IP. Business spectator report says the board intends to "liquidate assets". Seems like a fire sale of IP. If they can't sell it, I guess they might chase licensing but it will depend on how good the data looks--FDA was not overly impressed with their anti-abuse data. Not sure Walker will want to waste too much time; looks like a quick asset sale and bye bye birdie at the mo--esp. because they've dropped so many personnel.